Format

Send to

Choose Destination
Eur J Appl Physiol. 2014 Apr;114(4):763-71. doi: 10.1007/s00421-013-2811-8. Epub 2014 Jan 5.

Maximal strength, power, and aerobic endurance adaptations to concurrent strength and sprint interval training.

Author information

1
Body Composition and Physical Performance Laboratory, University of Oklahoma, Norman, OK, USA, g.s.cantrell@ou.edu.

Abstract

PURPOSE:

This study was designed to examine whether concurrent sprint interval and strength training (CT) would result in compromised strength development when compared to strength training (ST) alone. In addition, maximal oxygen consumption (VO2max) and time to exhaustion (TTE) were measured to determine if sprint interval training (SIT) would augment aerobic performance.

METHODS:

Fourteen recreationally active men completed the study. ST (n = 7) was performed 2 days/week and CT (n = 7) was performed 4 days/week for 12 weeks. CT was separated by 24 h to reduce the influence of acute fatigue. Body composition was analyzed pre- and post-intervention. Anaerobic power, one-repetition maximum (1RM) lower- and upper-body strength, VO2max and TTE were analyzed pre-, mid-, and post-training. Training intensity for ST was set at 85 % 1RM and SIT trained using a modified Wingate protocol, adjusted to 20 s.

RESULTS:

Upper- and lower-body strength improved significantly after training (p < 0.001) with no difference between the groups (p > 0.05). VO2max increased 40.9 ± 8.4 to 42.3 ± 7.1 ml/kg/min (p < 0.05) for CT, whereas ST remained unchanged. A significant difference in VO2max (p < 0.05) was observed between groups post-intervention (CT: 42.3 ± 7.1 vs. ST: 36.0 ± 3.0 ml/kg/min). A main effect for time and group was observed in TTE (p < 0.05). A significant main effect for time was observed in average power (p < 0.05).

CONCLUSION:

Preliminary findings suggest that performing concurrent sprint interval and strength training does not attenuate the strength response when compared to ST alone, while also improves aerobic performance measures, such as VO2max at the same time.

PMID:
24390691
DOI:
10.1007/s00421-013-2811-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center